Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1999;33:1135-1140

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Muntzel, M. S.
Right arrow Articles by Barrett, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Muntzel, M. S.
Right arrow Articles by Barrett, S.
Related Collections
Right arrow Nutrition
Right arrow Cardiovascular Pharmacology
Right arrow Hypertension - basic studies

(Hypertension. 1999;33:1135-1140.)
© 1999 American Heart Association, Inc.


Scientific Contributions

Metformin Attenuates Salt-Induced Hypertension in Spontaneously Hypertensive Rats

Martin S. Muntzel; Ibrahima Hamidou; Shean Barrett

From the Department of Biological Sciences, Lehman College (M.S.M., I.H.), and the Department of Biology, Bronx Community College, Bronx, NY (S.B.).

Correspondence to Martin S. Muntzel, PhD, Lehman College, Department of Biological Sciences, 250 Bedford Park Boulevard West, Bronx, NY 10468-1589. E-mail martinmu{at}alpha.lehman.cuny.edu

Abstract—Metformin, an antihyperglycemic agent used for treatment of type 2 diabetes mellitus, lowers blood pressure in humans and experimental animals. We recently demonstrated that short-term administration of metformin may lower blood pressure by reducing sympathetic neural outflow. The present studies were initiated to determine whether long-term administration of metformin blunts salt-induced hypertension, a condition characterized by elevated sympathetic activity. Male spontaneously hypertensive rats, in which radiotelemeters had been implanted for continuous monitoring of heart rate and blood pressure, were randomly assigned to groups that received vehicle (drinking water) or metformin (500 mg/kg per day) and ate a normal 0.3% NaCl diet and to groups that received vehicle or metformin and ate a high 8.0% NaCl diet for a period of 4 weeks. Although metformin did not affect blood pressure in the animals that ate the normal-salt diet (vehicle, 130±3 mm Hg; metformin, 133±5 mm Hg; mean±SEM), drug treatment blunted the rise in pressure caused by a high-salt diet (vehicle, 153±4 mm Hg; metformin, 140±5 mm Hg; P<0.001). In agreement, during direct pressure recordings in anesthetized rats, the animals that ate the high-salt diet had higher pressures (136±13 mm Hg) than those in the control (98±5 mm Hg, P<0.01), metformin (100±7 mm Hg, P<0.01), and metformin/high-salt groups (92±3 mm Hg, P<0.01). Finally, metformin lowered heart rate in rats that ate the normal- and high-salt diets (310±3 and 305±4 bpm) compared with rats that ate normal- and high-salt diets given vehicle (332±3 and 324±2 bpm, P<0.01). These data indicate that the chronic depressor actions of metformin are enhanced in animals with hypertension exacerbated by a high-salt diet.


Key Words: metformin • rats, inbred SHR • blood pressure • heart rate • sodium chloride, dietary




This article has been cited by other articles:


Home page
ANN INTERN MEDHome page
D. Kirpichnikov, S. I. McFarlane, and J. R. Sowers
Metformin: An Update
Ann Intern Med, July 2, 2002; 137(1): 25 - 33.
[Abstract] [Full Text] [PDF]